Galectin Therapeutics Inc. Warrants (GALTW)

[biotech2010]

It's always interesting to see how manipulators like Adam Feuerstein can throw garbage out publicly without any fear of recrimination.

He single handedly dropped GALT $2 in 10 minutes by doing that on Twitter this afternoon.

I don't care very much since, at end of the day, GALT will succeed on its data and the efficacy of GR-MD-02 or the next generation drug but it would be very easy to be upset by his antics.

I won't post his Twitter feed or respond but he has made accusations today about the lack of a clinical endpoint in their trial that are complete bs-the current trial is a PHASE 1, there is no clinical endpoint to discuss since Phase 1's are, by definition, safety-related.

Feuerstein is a disgrace, period, end of discussion.